Autori: Rejdak Konrad
| Naslov | Facilitated subcutaneous immunoglobulin 10% for CIDP: interim results from a long-term safety and tolerability study (Meeting Abstract) |
| Autori | Hadden R Andersen H Bril Vera Basta Ivana Z Rejdak Konrad Djordjevic G Greco E Hasan S French J Yel L Ay H |
| Info | EUROPEAN JOURNAL OF NEUROLOGY, (2023), vol. 30 br. , Suppl. 1, str. 286-286 |
| Projekat | Takeda Development Center Americas, Inc./Takeda Pharmaceuticals International AG |
| Ispravka | ISI/Web of Science Elečas Rang časopisa |
| Naslov | Treatment with Cladribine Tablets Beyond Year 4: A Position Statement by Southeast European Multiple Sclerosis Centers (Article; Early Access) |
| Autori | Habek Mario Drulovic Jelena S Jakob Gregor Brecl Barbov Ivan Radulovic Ljiljana Rajda Cecilia Rejdak Konrad Turcani Peter |
| Info | NEUROLOGY AND THERAPY, (2022), vol. br. , str. - |
| Projekat | Merck, Zagreb, Croatia |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Neurology training around the world: asking the trainees (Letter) |
| Autori | Rejdak Konrad Petzold Axel Ng Karl Afra Judit Dujmovic Irena Stelmasiak Zbigniew Ryglewicz Danuta Kwiecinski Hubert Grisold Wolfgang Vecsei Laszlo |
| Info | LANCET NEUROLOGY, (2010), vol. 9 br. 1, str. 32-33 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
